https://www.cigna.com/knowledge-center/hw/medications/lisocabtagene-maraleucel-injection-a621017
Lisocabtagene Maraleucel Injection | Cigna
Lisocabtagene maraleucel is used to treat certain types of large B-cell lymphoma (a type of cancer that begins in the white blood cells) in certain adults...
lisocabtagene maraleucelinjectioncigna
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2025-05516&r=1
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in...
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous...
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-breyanzi-lisocabtagene-maraleucel
FDA D.I.S.C.O. Burst Edition: Breyanzi (lisocabtagene maraleucel) | FDA
Listen to a soundcast of the Feb 5th 2021 FDA approval of Breyanzi for treatment of adult patients with relapsed or refractory large B-cell lymphoma after two...
d i s c ofda